COLL vs MAS · P/E 17, rev $181.9M vs P/E 18, rev $7.83B
Collegium Pharmaceutical Inc (COLL) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported MAS revenue for 2024-12-31 was $7.83B. Net income was $874.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the COLL and MAS stock pages for the full models.
Not investment advice.